Achieve Life Sciences Inc (ACHV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -16,395 | -12,687 | -10,583 | -1,234 | -828 |
| Depreciation Amortization | 254 | 282 | 282 | 223 | 140 |
| Income taxes - deferred | N/A | N/A | -3,051 | -504 | -407 |
| Accounts receivable | N/A | N/A | -9 | N/A | N/A |
| Accounts payable and accrued liabilities | 715 | -69 | 118 | 22 | 57 |
| Other Working Capital | -273 | 928 | -3,091 | 1,313 | 745 |
| Other Operating Activity | 483 | 923 | 7,227 | -22 | -57 |
| Operating Cash Flow | $-15,216 | $-10,623 | $-9,107 | $-202 | $-350 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 5,089 | -5,089 | N/A | N/A | N/A |
| PPE Investments | -53 | -36 | N/A | N/A | N/A |
| Other Investing Activity | 0 | 0 | 12,648 | 0 | -2,000 |
| Investing Cash Flow | $5,036 | $-5,125 | $12,648 | $N/A | $-2,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | 150 | 2,683 |
| Debt Repayment | N/A | N/A | N/A | N/A | -272 |
| Common Stock Issued | 4,199 | 18,478 | 64 | N/A | N/A |
| Other Financing Activity | 13,126 | 1,279 | 1,937 | 0 | 0 |
| Financing Cash Flow | $17,325 | $19,757 | $2,001 | $150 | $2,411 |
| Exchange Rate Effect | 4 | N/A | -1 | N/A | N/A |
| Beginning Cash Position | 9,565 | 5,556 | 15 | 67 | 6 |
| End Cash Position | 16,714 | 9,565 | 5,556 | 15 | 67 |
| Net Cash Flow | $7,149 | $4,009 | $5,541 | $-52 | $61 |
| Free Cash Flow | |||||
| Operating Cash Flow | -15,216 | -10,623 | -9,107 | -202 | -350 |
| Capital Expenditure | -53 | -46 | N/A | N/A | N/A |
| Free Cash Flow | -15,269 | -10,669 | -9,107 | -202 | -350 |